Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A decrease in drug resistance levels of the HIV epidemic can be bad news.

María S Sánchez1, Robert M Grant, Travis C Porco

  • 1Department of Environmental Science, Policy and Management, University of California, Berkeley, CA 94720, USA. msanchez@nature.berkeley.edu

Bulletin of Mathematical Biology
|May 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 Reproduction Numbers and Long COVID Prevalences in California State Prisons.

medRxiv : the preprint server for health sciences·2025
Same author

Mass azithromycin for prevention of child mortality among children with acute malnutrition: A subgroup analysis of a cluster randomized controlled trial.

PLOS global public health·2024
Same author

Large Language Models Can Enable Inductive Thematic Analysis of a Social Media Corpus in a Single Prompt: Human Validation Study.

JMIR infodemiology·2024
Same author

Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.

Ocular immunology and inflammation·2024
Same author

Suppressed HIV antibody responses following exposure to antiretrovirals-evidence from PrEP randomized trials and early antiretroviral treatment initiation studies.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2024
Same author

Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.

The New England journal of medicine·2024

Transient decreases in primary HIV resistance occurred in North America. This decline may paradoxically worsen the epidemic due to increased infections and drug resistance carriers, highlighting the need for improved control efforts.

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Transient decreases in primary HIV resistance have been observed in North American cities, including San Francisco.
  • Understanding the drivers of these changes is crucial for effective HIV epidemic control.

Purpose of the Study:

  • To identify potential causes for the observed transient decreases in primary HIV resistance.
  • To model the impact of different factors on HIV transmission and drug resistance dynamics.

Main Methods:

  • Utilized a staged compartmental Susceptible-Infected (SI) deterministic model.
  • Simulated scenarios involving changes in risky behavior, treatment access for acute HIV infections, and antiretroviral therapy regimens.

Main Results:

Related Experiment Videos

  • Three potential causes were identified: increased risky behavior, reduced treatment for acute HIV, and shifts in therapy (mono/dual to triple-drug).
  • Observed patterns most closely align with increased risky behavior.
  • Increased risky behavior can paradoxically lead to a worsening epidemic, with more infections and drug resistance carriers, despite a transient decrease in primary resistance proportion.

Conclusions:

  • The decline in primary HIV resistance may be a complex phenomenon driven synergistically by multiple factors.
  • Effective HIV epidemic control in developed nations requires enhanced public health interventions.
  • Drug-resistant HIV strains can serve as valuable epidemiological markers for monitoring the epidemic's trajectory.